A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care

Recruiting now · Not applicable

Conditions studied: Heart Failure

In brief

Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool (Wake and Weigh) to affect self-care and quality of life in a population of older adults with heart failure. This will be a randomized controlled pilot trial to test the methods to be used in a larger randomized controlled trial. The Self-care in Heart Failure Index and Kansas City Cardiomyopathy Questionnaire surveys will be given at admission and four weeks after discharge. The Wake and Weigh tool is designed to help patients track weight in the hospital and following discharge. Feasibility endpoints will be summarized descriptively.

Key facts

Study ID

NCT07184541

Run by

Lee Anne Siegmund

People needed

42

Starts

2024-11-01

Expected to finish

2026-12-01

Last updated by the study team

2025-09-24

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (55 years or older)
• New or existing diagnosis of HF (regardless of type or length of time since diagnosis).
• Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet).
• Must be able to read and communicate in English.
• Must be able to stand and weigh independently.
• Must have a scale at home, or ability to obtain one for the study.

You may not qualify if…

• Documented diagnosis of cognitive impairment.
• A Charlson Comorbidity Index (CCI) of >4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of >3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI >2 (Foraker et al., 2014).

Where it is running

• Cleveland Clinic Avon Hospital — Avon, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.